Printer Friendly

U.S. HEALTHCARE ANNOUNCES INTENT TO DIVIDEND ITS U.S. BIOSCIENCE HOLDINGS

 U.S. HEALTHCARE ANNOUNCES INTENT TO DIVIDEND
 ITS U.S. BIOSCIENCE HOLDINGS
 BLUE BELL, Pa., Feb. 3 /PRNewswire/ -- U.S. Healthcare, Inc. (NASDAQ: USHC), one of the nation's leading providers of managed health care services, announced today that it has advised U.S. Bioscience, Inc. (AMEX: UBS) and Marion Merrell Dow, Inc. (NYSE: MKC) of its intent to have registered and then distribute the 6.7 million U.S. Bioscience shares it now holds to the shareholders of U.S. Healthcare in the form of a special dividend.
 U.S. Healthcare provides managed health care services through its HMOs in Pennsylvania, New Jersey, New York, Delaware, Connecticut, Massachusetts, Maryland and New Hampshire. The company also provides a variety of managed health care services to self-insured and other employers.
 /delval/
 -0- 2/3/92
 /CONTACT: Costas C. Nicolaides, executive vp and chief financial officer of U.S. Healthcare, 215-283-6843/
 (USHC UBS MKC) CO: U.S. Healthcare, Inc.; U.S. Bioscience, Inc.; Marion Merrell Dow,
 Inc. ST: Pennsylvania IN: INS SU:


JS-MK -- PH025 -- 6232 02/03/92 13:25 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 3, 1992
Words:178
Previous Article:COASTAL'S ANR DECLARES DIVIDEND
Next Article:WHEELER NAMED TO HEAD CORPORATE BANKING FOR BARNETT BANK OF ATLANTA
Topics:


Related Articles
U.S. BIOSCIENCE REACHES AGREEMENT WITH MARION MERRELL DOW AND U.S. HEALTHCARE REGARDING STOCK DISTRIBUTION
MARION MERRELL DOW WITHDRAWS PLANNED SALE OF U.S. BIOSCIENCE COMMON STOCK
U.S. HEALTHCARE ANNOUNCES AGREEMENT TO DISTRIBUTE U.S. BIOSCIENCE SHARES
U.S. HEALTHCARE ANNOUNCES SPECIAL DIVIDEND OF ITS U.S. BIOSCIENCE HOLDINGS
U.S. HEALTHCARE REPORTS RESULTS FOR THE SECOND QUARTER
U.S. HEALTHCARE REPORTS RESULTS FOR THE THIRD QUARTER
Superior Consultant Holdings Corporation Announces Intent to Merge Superior Consultant Company, Inc. and Chi Systems, Inc.
Quintiles Transnational Commits To Bioscience Investment Fund.
ParAllele BioScience Secures $22.5 Million in Financing; Funds to Support Commercialization of ParAllele's Comprehensive Genetic Discovery Tools.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters